Veru Inc VERU

Consumer Defensive Household & Personal Products

Veru Inc. is a biopharmaceutical company. The Company is focused on developing medicines for the for the treatment of hospitalized COVID-19 patients at high risk for acute respiratory distress syndrome (ARDS) and other viral-related ARDS and for the management of breast and prostate cancers. The Company offers two FDA approved products within its sexual health program, including ENTADFI (tadalafil 5mg and finasteride 5mg capsule), for the treatment of benign prostatic hyperplasia and FC2 Female Condom (internal condom) (FC2), for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. Its breast cancer drug pipeline has four clinical development programs for two drugs, such as enobosarm, an oral selective androgen receptor targeting agonist, and sabizabulin, an oral cytoskeleton disruptor. Its prostate cancer drug pipeline includes sabizabulin, VERU-100 and zuclomiphene citrate.

NDAQ:VERU - Post by User

Veru Inc

<< Previous

Bullboard Posts

Next >>

Post by AviseAnalyticson Jul 08, 2022 8:02am

193 Views

Post# 34810477

HERE’S A ROUND-UP ON VERU INC!

$VERU

Veru, Inc. (NASDAQ: VERU) announced positive results from a Phase 3 study evaluating the safety and efficacy of oral sabizabulin for the treatment of hospitalized moderate-severe COVID-19 patients at high risk for acute respiratory distress syndrome (ARDS) and death.

Here's a quick round-up on the Company! Read on to know more:

https://www.aviseanalytics.com/heres-a-round-up-on-veru-inc/

<< Previous

Bullboard Posts

Next >>

Junior copper miner secures another major partner